Volume 29, Number 2—February 2023
Dispatch
Neoehrlichiosis in Symptomatic Immunocompetent Child, South Africa
Table
Investigation | Patient result | Reference value or range |
---|---|---|
C-reactive protein, mg/L | 17.2 | <5 |
Leukocytes, × 109 cells/L | 15.8 | 4.5–13.5 |
Neutrophils, × 109 cells/L | 10.98 | 1.50–8.5 |
Lymphocytes, × 109 cells/L | 2.99 | 1.0–6.5 |
Monocytes, × 109 cells/L | 1.50 | 0–0.8 |
Platelets, × 109 cells /L | 219 | 140–420 |
Hemoglobin, g/dL |
12.7 |
11.5–15.5 |
Blood cultures | No growth | NA |
Urine culture | No growth | NA |
Rickettsia conorii/R. africae serology and PCR on blood | Negative | NA |
SARS-CoV-2 PCR, nasopharyngeal swab and serology | Negative | NA |
Cytomegalovirus PCR and serology | Negative | NA |
Epstein-Barr serology | Negative | NA |
Widal test | Negative | NA |
Mastazyme Brucella ELISA | IgM and IgG equivocal | NA |
Multiplex PCR for atypical and viral respiratory pathogens* | Negative | NA |
QuantiFERON Gold test for tuberculosis† |
Negative |
NA |
Imaging | ||
Ultrasound of the abdomen | 15 cm spleen | 10–11 cm at this age |
Chest radiograph | No abnormalities detected | NA |
Cervical and thoracic spine radiograph | No abnormalities detected | NA |
Transthoracic echocardiography | No abnormalities detected | NA |
Magnetic resonance imaging spine | No abnormalities detected | NA |
*FilmArray RP2.1plus (BioFire Diagnostics, https://www.biofiredx.com). †QuantiFERON, https://www.quantiferon.com.
1These authors contributed equally to this article.
Page created: December 22, 2022
Page updated: January 21, 2023
Page reviewed: January 21, 2023
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.